Trial Profile
Phase I trial of JTE 151
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs JTE 151 (Primary)
- Indications Autoimmune disorders; Hypersensitivity
- Focus Adverse reactions; First in man
- Sponsors Japan Tobacco
- 14 Apr 2016 New trial record